Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Cash Flows

v3.25.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Statement of Cash Flows [Abstract]    
Cash and cash equivalents, beginning of period $ 8,249 $ 7,079
Cash flows provided by (used for) operating activities:    
Net income (loss) (3,911) (2,091)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 5,213 4,403
Share-based compensation 1,348 1,959
Restructuring and other charges 382 219
Amortization of intangibles 474 717
(Gains) losses on equity investments, net (390) (84)
Deferred taxes 106 (1,339)
Impairments and net (gain) loss on retirement of property, plant, and equipment 482 126
Changes in assets and liabilities:    
Accounts receivable 1,004 272
Inventories 99 (116)
Accounts payable 114 181
Accrued compensation and benefits 1,022 (1,015)
Income taxes (1,338) (835)
Other assets and liabilities (1,742) (1,328)
Total adjustments 6,774 3,160
Net cash provided by operating activities 2,863 1,069
Cash flows provided by (used for) investing activities:    
Additions to property, plant and equipment (8,733) (11,652)
Proceeds from capital-related government incentives 964 699
Purchases of short-term investments (5,730) (17,634)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 8,575 17,214
Proceeds from divestiture 1,935 0
Other investing 984 (355)
Net cash used for investing activities (2,005) (11,728)
Cash flows provided by (used for) financing activities:    
Issuance of commercial paper, net of issuance costs 3,493 5,804
Repayment of commercial paper (1,496) (2,609)
Partner contributions 2,238 11,861
Additions to property, plant, and equipment (1,962) 0
Issuance of long-term debt, net of issuance costs 0 2,975
Repayment of debt (1,500) (2,288)
Proceeds from sales of common stock through employee equity incentive plans 491 631
Payment of dividends to stockholders 0 (1,063)
Other financing (678) (444)
Net cash provided by (used for) financing activities 586 14,867
Net increase (decrease) in cash and cash equivalents 1,444 4,208
Cash and cash equivalents, end of period 9,693 [1] 11,287
Non-cash supplemental disclosures:    
Acquisition of property, plant, and equipment2 5,155 [2] 5,544
Recognition of capital-related government incentives 1,452 1,281
Interest, net of capitalized interest 514 488
Income taxes, net of refunds $ 1,793 $ 1,555
[1] ncludes cash recorded within other current assets on the Consolidated Condensed Balance Sheets relating to Altera cash held for sale. Refer to "Note 9: Divestitures" for additional information.
[2] Includes $960 million with extended payment terms of greater than 90 days in the six months ended June 28, 2025.